Article Details

C4X Discovery Signs Licensing Deal with AstraZeneca Worth up to $402 Mln - MarketWatch

Retrieved on: 2022-11-28 07:35:59

Tags for this article:

Click the tags to see associated articles and topics

C4X Discovery Signs Licensing Deal with AstraZeneca Worth up to $402 Mln - MarketWatch. View article details on hiswai:

Excerpt

The company said AstraZeneca will develop and commercialize an oral therapy for the treatment of inflammatory and respiratory diseases, with a lead ...

Article found on: www.marketwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up